SUNJIN NEWSLETTER
Introducing Ceraplex: SCI-Validated High-Concentration Ceramide Stabilization Platform Technology
Translated by Choi, Seolha
July 2025, NO.29
Hi, how are you?
Through Ceraplex, Sunjin Beauty Science’s proprietary ceramide stabilization platform technology that overcomes existing limitations, we propose a solution that enables stable formulation of poorly soluble ceramides at high concentrations.
Sunjin Beauty Science has elucidated the stabilization mechanism and moisturizing efficacy of the CERAPLEX series, and this research has been published in an SCI journal (Journal of Materials Chemistry B, Impact Factor 6.1), proving it to be a globally recognized technology.
*What is Journal of Materials Chemistry B? : A prestigious academic journal published by the Royal Society of Chemistry (RSC), focusing on functional materials for life sciences and medical applications, including biocompatible materials and drug delivery systems.
The Ceraplex series is a Ceramide delivery system stabilized using the world’s first proprietary technology to enable easy use of high-concentration ceramides in both oil and aqueous phases.
Conventional drug delivery systems rely on organic materials like low molecular weight surfactants or lecithin for stabilization in liposome or emulsion forms, whereas Sunjin Beauty Science stabilizes poorly soluble substances using hectorite nanoclay materials.
The hectorite-based Ceraplex series encapsulates ceramides with hectorite, preventing the fusion of lamella bridges and thereby achieving greater stability compared to conventional ceramide stabilization technologies like liposomes.
The Ceraplex series is an enhanced-stability ceramide delivery system offering selective application based on emulsion type (W/O, O/W) and ceramide variety (natural, synthetic).
For any inquiries regarding our products, please feel free to contact us at the following.
Areum Jeong / Regional Sales Manager
E-mail : sales1@sunjinbs.com
